Pharmaceutical - Actavis

Filter

Current filters:

Actavis

Popular Filters

1 to 25 of 51 results

Actavis to acquire Durata Therapeutics for $675 million

Actavis to acquire Durata Therapeutics for $675 million

06-10-2014

In a move that takes it further out of its main generics business, Ireland-headquartered Actavis has…

ActavisAntibiotics and Infectious diseasesDalvanceDurata TherapeuticsIrelandMergers & AcquisitionsPharmaceutical

Salix terminates merger with Cosmo, now allegedly seeking deal with Actavis

Salix terminates merger with Cosmo, now allegedly seeking deal with Actavis

03-10-2014

Gastrointestinal specialist Salix Pharmaceuticals is reportedly seeking a deal with Ireland-headquartered…

ActavisCosmo PharmaceuticalsGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalSalixUSA

Actavis approached by Pfizer in latest takeover deal, according to sources

Actavis approached by Pfizer in latest takeover deal, according to sources

24-09-2014

US pharma giant Pfizer has held talks regarding an acquisition of Ireland-headquartered generics major…

ActavisMergers & AcquisitionsPfizerPharmaceuticalUSA

MMIP formally established to boost medicines manufacturing in the UK

23-09-2014

A new Medicines Manufacturing Industry Partnership (MMIP) has been jointly established by the Association…

ActavisEisaiFujifilm Diosynth BiotechnologiesGlaxoSmithKlineOxford BioMedicaPfizerPharmaceuticalProductionUK

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

10-09-2014

Ireland-based generic drug major Actavis yesterday confirmed that the US Food and Drug Administration's…

ActavisCardio-vascularnebivololPharmaceuticalRegulationUSAvalsartan

FDA accepts Actavis’ NDA for ceftazidime-avibactam

FDA accepts Actavis’ NDA for ceftazidime-avibactam

05-09-2014

Ireland-headquartered generic drugs major Actavis today confirmed that the US Food and Drug Administration…

ActavisAntibiotics and Infectious diseasesceftazidime-avibactamPharmaceuticalRegulationResearchUSA

FDA accepts Actavis NDA for eluxadoline

FDA accepts Actavis NDA for eluxadoline

03-09-2014

Ireland-headquartered generic drug major Actavis says that the US Food and Drug Administration has accepted…

ActaviseluxadolineForest LaboratoriesFuriex PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

22-08-2014

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer…

ActavisAstraZenecaBusiness FinanceIrelandMergers & AcquisitionsPfizerPharmaceuticalSwedenUKUnited StatesUSA

Depomed prevails in Gralise ANDA litigation with Actavis

Depomed prevails in Gralise ANDA litigation with Actavis

20-08-2014

US drug maker Depomed saw its shares climb more than 12% to $14.76 on Tuesday, on the news that the firm…

ActavisDepomedGraliseLegalNeurologicalPatentsPharmaceuticalUSA

Actavis reports 2nd-qtr revenues increase by over a third

Actavis reports 2nd-qtr revenues increase by over a third

05-08-2014

Ireland-headquartered generics major Actavis has reported a 34% boost in revenue in the second quarter…

ActavisActavis PharmaBusiness FinanceBusiness FinanceFinancialIrelandPharmaceutical

Shire gets positive ruling on Vyvanse patents from US district court

25-06-2014

Ireland-headquartered drugmaker Shire, which is defending itself from a $46 billion unsolicited bid from…

ActavisAmneal PharmaLegalMylanNeurologicalPatentsPharmaceuticalRoxaneSandozShireUSAVyvanse

Forest appeases shareholders over Actavis deal

30-05-2014

US drugmaker Forest Laboratories has reached a settlement with shareholders over its deal with generics…

ActavisBusinessBusiness FinanceEnvironmentForest LaboratoriesMajorMergers & AcquisitionsNew York Stock ExchangePharmaceuticalUSA

Actavis announces proposed Senior Leadership Team

Actavis announces proposed Senior Leadership Team

14-05-2014

US generics major Actavis (NYSE: ACT) has announced the proposed senior management team that will lead…

ActavisBiosimilarsBoardroomForest LaboratoriesPharmaceuticalUSA

US FTC releases 2013 highlights, including action against Actavis and Mylan

US FTC releases 2013 highlights, including action against Actavis and Mylan

01-04-2014

The US Federal Trade Commission chairwoman Edith Ramirez has released the agency’s 2013 Annual Highlights,…

ActavisMylan LaboratoriesPharmaceuticalRegulationUSA

US FDA approves NDA from Actavis and Valeant

US FDA approves NDA from Actavis and Valeant

26-03-2014

US generics major Actavis and Canada’s Valeant Pharmaceuticals said that the US Food and Drug Administration…

ActavisCanadaGenericsMetronidazolePharmaceuticalRegulationUSAValeant PharmaceuticalsWomen's Health

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

Actavis confirms plan to acquire Forest Labs for about $25 billion

Actavis confirms plan to acquire Forest Labs for about $25 billion

18-02-2014

After a morning of speculation and rumors, generics drug major Actavis today confirmed that it has reached…

ActavisForest LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

Merrimack and Actavis collaborate to develop specialty drugs

26-11-2013

USA-based Merrimack Pharmaceuticals and generics drug major Actavis have entered into a collaboration…

ActavisMerrimack PharmaceuticalsPharmaceuticalProductionResearch

Avanir Pharma settles Nuedexta patent litigation with Actavis

03-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

Actavis gains global rights for antifungal agent albaconazole

06-08-2013

US generic drugs major Actavis (NYSE: ACT),which also has strong interests in women's health products,…

ActavisalbaconazoleGlobalLicensingPalau PharmaPharmaceuticalWomen's Health

1 to 25 of 51 results

Back to top